NCT00492726 - Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem | Biotech Hunter

Enrollment

804

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Infection

Interventions

DRUG

Moxifloxacin (Avelox, BAY12-8039)

Moxifloxacin, 400mg, administered intravenously once daily

DRUG

Ertapenem intravenous

Active treatment: Ertapenem 1.0g, administered intravenously once daily

Trial Locations (52)

1002

Riga

1070

Bruxelles - Brussel

1090

Bruxelles - Brussel

1431

Sofia

1606

Sofia

1657

De Febrero 3

1888

San Juan Bautista

3402

Liepāja

5000

Córdoba

5800

Pleven

7002

Rousse

7130

Somerset West

7500

Cape Town

9000

Ghent

10207

Vilnius

15848

Beeskow

25000

Besançon

28007

Madrid

30322

Kohtla-Järve

30625

Hanover

31048

Haifa

33098

Paderborn

45130

Kaunas

45207

Amilly

66424

Homburg

69120

Heidelberg

115280

Moscow

119048

Moscow

214019

Smolensk

300748

Timișoara

400006

Cluj-Napoca

4428164

Kfar Saba

B1702FWM

Ciudadela

B1712FJN

Merlo

C1180AAX

Buenos Aires

Unknown

Mendoza

Rosario

Capital Federal

Rēzekne

Brasov

Oradea

EE-13419

Tallinn

EE-51014

Tartu

265 00

Rio Patras

LV-5417

Daugavpils

LV-1038

Riga

LV-4201

Valmiera

LT-92231

Klaipėda

LT-04130

Vilnius

022328

Bucharest

0001

Pretoria

08907

L'Hospitalet de Llobregat